AIP_PetriDishLab_969x267v2_km_RF
Project

Antibiotics and Innovation Project

Status:
Active

Antibiotics and Innovation Project

Project Contact

Joshua Wenderoff Senior Officer, Communications, Medical Safety Portfolio Tel: 202-540-6542
Email:

Project Focus:

Antibiotics save untold numbers of human lives every day. Modern medicine depends on their ability to treat and prevent infections such as pneumonia, tuberculosis, and staph. Yet drug-resistant bacteria are spreading in the nation’s communities and too often antibiotics are taken for granted. The U.S. Centers for Disease Control and Prevention estimates that tens of thousands of Americans die each year from infections, and many of those deaths are associated with bacteria that are resistant to treatment by one or more of these drugs. In the past few years, so-called “superbugs” have emerged that cause an even greater public health concern.

The history of antibiotics has repeated itself: drugs are discovered, but bacterial evolution can soon render them ineffective in treating infections. Resistance is fueled by injudicious use of existing drugs and compounded by a failure to develop novel new ones. Many major pharmaceutical companies have limited their investments in this antibiotic innovation, and only two new classes of these substances have reached the market in the past 30 years.

The Pew Charitable Trusts’ Antibiotics and Innovation Project develops and supports policies that will spur innovation of new antibiotics to fight infections today and to ensure a healthy nation in the future.

Recent Outbreak Stresses Need for New Antibiotics

Recent Outbreak Stresses Need for New Antibiotics Video

On August 22, researchers at the National Institute of Health released a scientific paper detailing the use of advanced genetic technology to trace a deadly infection, untreatable by nearly every antibiotic, that spread through the NIH’s Clinical Center last year.

Full Story

MRSA: A Deadly Pathogen with Fewer and Fewer Treatment Options

MRSA: A Deadly Pathogen with Fewer and Fewer Treatment Options Issue Brief

Staphylococcus aureus, or staph, is a common bacterium that exists in our environment and our bodies. Most of the time it does no harm. Sometimes, however, it can cause infection and require treatment. MRSA refers to strains of S. aureus that are resistant to the antibiotic methicillin and a host of other drugs used to treat infection.

Full Story